GeneWard Analytics

GeneWard Analytics is a Cape Town genomic-analysis outfit with six full-time staff, an office overlooking Table Mountain, and a client roster split between continental African public health programs and three quietly-anonymous European foundations that fund the public-health work without wanting their names on the deliverables. The founder is a former international-agency consultant who left for reasons she summarizes as “too many meetings, too few decisions.”

Their models specialize in regional-pattern epidemiology — disease-spread prediction tuned to specific cultural mobility patterns, vaccine-program optimization, the kind of work that requires understanding both molecular biology and how people actually move between villages on market day. Foundation contracts pay in five-figure Cu per study, occasionally clearing into low six figures when an international body is involved. The work is unglamorous, undercompensated, and the firm survives on the founder’s stubborn unwillingness to fail.

The office wall, behind the founder’s desk, holds a framed black-and-white photograph of a clinic she worked at in her twenties. The clinic no longer exists. She does not discuss it.

GeneWard maintains a small archive of training data the founder collected personally over fifteen years of fieldwork. The data has never been licensed, sold, or shared outside the firm. The founder considers it her insurance policy: as long as it exists, no larger firm can replicate her models without doing the fieldwork themselves. She does not expect any of them to bother.